These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6224677)

  • 21. Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin.
    Kirby CP
    J Antimicrob Chemother; 1984 May; 13 Suppl B():107-12. PubMed ID: 6234270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL; Ohm-Smith MJ; Hadley WK
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract]   [Full Text] [Related]  

  • 23. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
    Nakamura S; Nakata K; Katae H; Minami A; Kashimoto S; Yamagishi J; Takase Y; Shimizu M
    Antimicrob Agents Chemother; 1983 May; 23(5):742-9. PubMed ID: 6223579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal intraprostatic concentrations of norfloxacin.
    Bologna M; Vaggi L; Forchetti CM; Martini E
    Lancet; 1983 Jul; 2(8344):280. PubMed ID: 6135100
    [No Abstract]   [Full Text] [Related]  

  • 26. [Norfloxacin: a new oral chemotherapeutic agent effective against multi-drug-resistant Gram-negative bacteria and cocci. Rational directions for treatment].
    Panichi G; Magnanelli S; Giuliano M; Manzo M; Vetere A; Testore GP
    G Ital Chemioter; 1984; 31(1-2):65-71. PubMed ID: 6236125
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of norfloxacin in renal failure.
    Fillastre JP; Hannedouche T; Leroy A; Humbert G
    J Antimicrob Chemother; 1984 Oct; 14(4):439. PubMed ID: 6238930
    [No Abstract]   [Full Text] [Related]  

  • 30. The antimicrobial spectrum of norfloxacin.
    Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nalidixic acid plus sodium citrate twice daily in the treatment of acute urinary tract infection. Swedish Collaborative Study Group.
    Scand J Prim Health Care; 1988 Feb; 6(1):59-63. PubMed ID: 3281205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of urinary tract infection in the elderly.
    Bendall MJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():69-78. PubMed ID: 6234278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norfloxacin--a review of pharmacology and tissue penetration.
    Wise R
    J Antimicrob Chemother; 1984 May; 13 Suppl B():59-64. PubMed ID: 6234277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of a 3-day course of Mictral with a 7-day course of ampicillin in the treatment of urinary tract infection.
    Winwick JG; Savage SJ
    J Int Med Res; 1981; 9(1):58-61. PubMed ID: 7202832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with the use of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon)].
    Kelenhegyi M; Szabó Z; Soltész I; Varga A
    Orv Hetil; 1978 Sep; 119(37):2267-9. PubMed ID: 358051
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
    Esko E; Renkonen OV
    Scand J Infect Dis; 1985; 17(1):95-8. PubMed ID: 3158071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on distribution of two nalidixic acid analogs in otorhinolaryngological field.
    Murai K; Baba S
    Auris Nasus Larynx; 1982; 9(1):45-52. PubMed ID: 6217806
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the effects of gentamicin and other chemotherapeutic agents in experimental urinary tract infections].
    Prát V; Konícková L
    Cas Lek Cesk; 1970 Apr; 109(17):378-81. PubMed ID: 5443121
    [No Abstract]   [Full Text] [Related]  

  • 40. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
    Wise R; Lockley R; Webberly M; Adhami ZN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.